Abstract
Immunotherapy is already a revolution in oncology. Moreover, combined immunotherapy has shown very good results in some cancers. New kind of immune-related adverse events (irAEs) have been related with immunotherapy due to the stimulation of immune system and some of them concerning endocrine system (endocrine irAEs) can be severe with significant clinical consequences.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
